I.M. Injections
There is a change in preferred IM injection sites to no longer use the dorsogluteal site.
This poster is on the door of the medicaiton room in North Charleston. I wanted to place a picture on the blog for reference.
Key
Points:
¢ The dorsogluteal IM injection site will be removed as a medication
administration option from
McKesson and EPIC EMRs.
¢ In accordance with evidence-based practice guidelines, the dorsogluteal
site is not recommended for
intramuscular (IM) injection in the pediatric and adult patient populations.
¢ Rationale: The dorsogluteal site is
associated with the following:
¢ Sciatic
nerve injury
¢ Muscle
fibrosis
¢ Unnecessary
pain
¢ Inadvertent
subcutaneous administration
¢ Weakened or
amplified medication effects due to increased or decreased absorption
How will this affect your practice?
¢ Clinicians should no longer use the dorsogluteal site for administering
IM injections as recommended
by evidence based practice guidelines.





.jpg)
.jpg)










